Safety and Efficacy Study With Allergen Extracts of House Dust Mites for Specific Sublingual Immunotherapy
Clinical trial NCT01014325 · UNKNOWN
Trial details
- NCT number
- NCT01014325
- Sponsor
- Roxall Medizin
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2017-09-01
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.